(Q32060394)

English

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M H Gotfried

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

C A DeAbate

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

C Fogarty

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

C P Mathew

4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

W N Sokol

5

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

97-107

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Treatment cost of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious exacerbations of chronic bronchitis: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Confronting drug-resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic noncompliance and waste in upper respiratory infections and acute diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980033-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80033-3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32060394&oldid=1542567669"